This specialty practice discussion group is intended for advanced practice professionals of... View more
This specialty practice discussion group is intended for advanced practice professionals of APHON. Remember that anything published in this community can be seen by any member of the community. Please be considerate of the HIPAA Privacy Rule when posting to the community.
Are you sure you want to leave ?
Reply To: Dinutuximab (ch 14.18) in Osteosarcoma pt’s – AOST1421
We’ve recently had an Osteo patient get the drug. He did fine. Same side effects as with Neuroblastoma. He’s already gotten a couple of courses of it.
Sent from my iPhone
Would anyone be willing to share their experience with a Osteosarcoma patient receiving Dinutuximab IV over 2 days for recurrent disease in the lungs that has been completely resected for patients that have been enrolled on study AOST1421? Are they tolerating Dinutux over 2 days? Any other issues or side effects seen that wasn’t seen in the Neuroblastoma patients? Would appreciate any input or any helpful tips or suggestions as we get ready to enroll our first Osteo patient to receive this therapy and start in a few weeks. Thanks so much!
—————————— Michele Pope, PPCNP-BC,CPON,MSN Pediatric Nurse Practitioner Arnold Palmer Hospital for Children Orlando, FL United States ——————————